26360 Federal Register / Vol. 87, No. 86 / Wednesday, May 4, 2022 / Notices 

and associated materials (see 

ADDRESSES). 

CMS–460 Medicare Participating 

Physician or Supplier Agreement 

Under the PRA (44 U.S.C. 3501– 

3520), federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

The term ‘‘collection of information’’ is 

defined in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA 

requires federal agencies to publish a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, before 

submitting the collection to OMB for 

approval. To comply with this 

requirement, CMS is publishing this 

notice. 

Information Collection 

1. Title of Information Collection: 

Medicare Participating Physician or 

Supplier Agreement; Type of 

Information Collection Request: 

Revision with change of a currently 

approved collection; Use: Form CMS– 

460 is the agreement a physician, 

supplier, or their authorized official 

signs to become a participating provider 

in Medicare Part B. By signing the 

agreement to participate in Medicare, 

the physician, supplier, or their 

authorized official agrees to accept the 

Medicare-determined payment for 

Medicare covered services as payment 

in full and to charge the Medicare Part 

B beneficiary no more than the 

applicable deductible or coinsurance for 

the covered services. For purposes of 

this explanation, the term ‘‘supplier’’ 

means certain other persons or entities, 

other than physicians, that may bill 

Medicare for Part B services (e.g., 

suppliers of diagnostic tests, suppliers 

of radiology services, durable medical 

suppliers (DME) suppliers, nurse 

practitioners, clinical social workers, 

physician assistants). Institutions that 

render Part B services in their outpatient 

department are not considered 

‘‘suppliers’’ for purposes of this 

agreement. Form Number: CMS–460 

(OMB control number: 0938–0373); 

Frequency: Annually; Affected Public: 

Private Sector, Business or other forprofits; Number of Respondents: 36,000; 

Number of Responses: 36,000; Total 

Annual Hours: 9,000. (For questions 

regarding this collection contact Mark 

G. Baldwin at 410–786–8139.) 

Dated: April 29, 2022, 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2022–09574 Filed 5–3–22; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the National Vaccine 

Advisory Committee 

AGENCY: Office of Infectious Disease and 

HIV/AIDS Policy, Office of the Assistant 

Secretary for Health, Office of the 

Secretary, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the 

Department of Health and Human 

Services (HHS) is hereby giving notice 

that the National Vaccine Advisory 

Committee (NVAC) will hold an inperson meeting. The meeting will be 

open to the public and public comment 

will be heard during the meeting. 

DATES: The meeting will be held June 

15–16, 2022. The confirmed meeting 

times and agenda will be posted on the 

NVAC website at http://www.hhs.gov/ 

nvpo/nvac/meetings/index.html as soon 

as they become available. 

ADDRESSES: Instructions regarding 

attending this meeting will be posted 

online at: http://www.hhs.gov/nvpo/ 

nvac/meetings/index.html at least one 

week prior to the meeting. Preregistration is required for those who 

wish to attend the meeting or participate 

in public comment. Please register at 

http://www.hhs.gov/nvpo/nvac/ 

meetings/index.html. 

FOR FURTHER INFORMATION CONTACT: Ann 

Aikin, Acting Designated Federal 

Officer, at the Office of Infectious 

Disease and HIV/AIDS Policy, U.S. 

Department of Health and Human 

Services, Mary E. Switzer Building, 

Room L618, 330 C Street SW, 

Washington, DC 20024. Email: nvac@

hhs.gov. 

SUPPLEMENTARY INFORMATION: Pursuant 

to Section 2101 of the Public Health 

Service Act (42 U.S.C. 300aa–1), the 

Secretary of HHS was mandated to 

establish the National Vaccine Program 

to achieve optimal prevention of human 

infectious diseases through 

immunization and to achieve optimal 

prevention against adverse reactions to 

vaccines. The NVAC was established to 

provide advice and make 

recommendations to the Director of the 

National Vaccine Program on matters 

related to the Program’s responsibilities. 

The Assistant Secretary for Health 

serves as Director of the National 

Vaccine Program. 

The NVAC will hear presentations on 

innovation for immunization, vaccine 

safety, and communication, and 

surveillance. Please note that agenda 

items are subject to change, as priorities 

dictate. Information on the final meeting 

agenda will be posted prior to the 

meeting on the NVAC website: http://

www.hhs.gov/nvpo/nvac/index.html. 

Members of the public will have the 

opportunity to provide comment at the 

NVAC meeting during the public 

comment period designated on the 

agenda. Public comments made during 

the meeting will be limited to three 

minutes per person to ensure time is 

allotted for all those wishing to speak. 

Individuals are also welcome to submit 

written comments in advance. Written 

comments should not exceed three 

pages in length. Individuals submitting 

comments should email their written 

comments or their request to provide a 

comment during the meeting to nvac@

hhs.gov at least five business days prior 

to the meeting. 

Dated: April 5, 2022. 

Ann Aikin, 

Acting Designated Federal Official, Office of 

the Assistant Secretary for Health. 

[FR Doc. 2022–09551 Filed 5–3–22; 8:45 am] 

BILLING CODE 4150–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Solicitation of Nominations for 

Membership on the National Vaccine 

Advisory Committee 

AGENCY: Department of Health and 

Human Services, Office of the Secretary, 

Office of the Assistant Secretary for 

Health, Office of Infectious Disease and 

HIV/AIDS Policy. 

ACTION: Notice. 

SUMMARY: The Office of Infectious 

Disease and HIV/AIDS Policy (OIDP), a 

program office within the Office of the 

Assistant Secretary for Health, 

Department of Health and Human 

Services (HHS), solicits nominations of 

qualified candidates to be considered 

for appointment to the National Vaccine 

Advisory Committee (NVAC). The 

activities of this committee are governed 

by the Federal Advisory Committee Act 

(FACA). 

The NVAC serves an advisory role, 

providing recommendations to the 

Assistant Secretary for Health in her 

capacity as the Director of the National 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 86 / Wednesday, May 4, 2022 / Notices 26361 

Vaccine Program. The committee 

studies and recommends ways to 

encourage the availability of an 

adequate supply of safe and effective 

vaccination products in the United 

States, as well as research priorities and 

other measures to enhance the safety 

and efficacy of vaccines. The committee 

also advises the Assistant Secretary for 

Health on the implementation of 

sections 300aa–2, 300aa–3, and 300aa– 

4 of the Public Health Service (PHS) 

Act, including government and nongovernment cooperation. 

A copy of the NVAC charter that 

describes its structure and functions and 

lists of the current members can be 

reviewed on the NVAC website at: 

http://www.hhs.gov/nvpo/nvac/ 

index.html. 

Submission Process: Please email all 

submissions to nvac@hhs.gov. All 

nominations for membership on the 

committee must be received no later 

than 5:00 p.m. EDT on June 24, 2022. 

FOR FURTHER INFORMATION CONTACT: Ann 

Aikin, Acting Designated Federal 

Officer, U.S. Department of Health and 

Human Services, Office of the Assistant 

Secretary for Health, Office of Infectious 

Disease and HIV/AIDS Policy, Mary E. 

Switzer Building, Room L618, 330 C 

Street SW, Washington, DC 20024. 

Email: nvac@hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Committee Function, Qualifications, 

and Information Required: As part of an 

ongoing effort to enhance deliberations 

and discussions with the public on 

vaccines and immunization, 

nominations are being sought for 

interested individuals to serve on the 

NVAC. Committee members provide 

peer review, consultation, advice, and 

recommendations to the Assistant 

Secretary for Health, in her capacity as 

the Director of the National Vaccine 

Program. Individuals selected for 

appointment to the NVAC will serve as 

voting members. The NVAC consists of 

17 voting members: 15 public members 

and 2 representative members. 

Individuals selected for appointment to 

the NVAC can be invited to serve terms 

of up to four years. Selection of 

members is based on candidates’ 

qualifications to contribute to the 

accomplishment of the NVAC’s 

objectives. Interested candidates should 

demonstrate a willingness to commit 

time to NVAC activities and the ability 

to work constructively and effectively 

on committees. 

Public Members: Public members are 

individuals who are appointed to the 

NVAC to exercise their independent 

best judgment on behalf of the 

government. It is expected that public 

members will discuss and deliberate in 

a manner that is free from conflicts of 

interest. Public members to the NVAC 

shall be selected from individuals who 

are engaged in vaccine research or the 

manufacture of vaccines, or who are 

health care providers, members of 

parent organizations concerned with 

immunizations, representatives of state 

or local health agencies, or public health 

organizations. 

Representative Members: 

Representative members are individuals 

appointed to the NVAC to provide the 

views of industry or a special interest 

group. NVAC representative members 

serve specifically to represent the 

viewpoints or perspectives of the 

vaccine manufacturing industry or 

groups engaged in vaccine research or 

the manufacture of vaccines. 

This announcement is to solicit 

nominations of qualified candidates to 

fill positions in the public and 

representative member category of the 

NVAC. Applications received in 

response and not appointed may also be 

considered for future vacancies that 

occur. 

Travel reimbursement provided to the 

committee: All NVAC members are 

authorized to receive reimbursement for 

travel expenses that are incurred to 

attend meetings and conduct authorized 

NVAC-related business, in accordance 

with standard government travel 

regulations. All other services that are 

performed by the public members 

outside the committee meetings shall be 

provided without compensation. 

Expertise sought for the National 

Vaccine Advisory Committee: To 

enhance the diversity of expertise on the 

committee, OIDP seeks nominations of 

diverse individuals in the following 

disciplines/topic areas: 

• Vaccine innovation and/or research 

and development; 

• vaccine safety; 

• vaccine access and financing; 

• health information technologies and 

immunization information systems; 

• immunization program 

implementation and management; and 

• vaccine communications. 

How to submit nominations: The 

following information should be 

included in the package of materials 

submitted for each nominee: (1) A letter 

of nomination that clearly states the 

name and affiliation of the nominee, the 

basis for the nomination (i.e., specific 

attributes that qualify the nominee for 

service in this capacity); and a statement 

that the nominee is willing to serve as 

a member of the committee; (2) the 

nominator’s name, address, daytime 

telephone number, home and/or work 

address, and email address; (3) a current 

copy of the nominee’s curriculum vitae 

(no longer than 10 pages); and (4) a 

short biographical sketch (no more than 

350 words). All documentation must be 

received in a legible font, such as Times 

New Roman 12 point, for a nomination 

to be considered. 

Please note that nominees will not 

receive updates on the status of their 

nomination, and the nomination process 

can take many months. Information on 

nominees appointed to the committee 

will be posted to the NVAC website at 

http://www.hhs.gov/nvpo/nvac/ 

members/index.html. 

Individuals can nominate themselves 

for consideration of appointment to the 

committee. Incomplete nominations 

will not be processed. Federal 

employees should not be nominated for 

appointment to this committee. 

HHS makes efforts to ensure that the 

membership of federal advisory 

committees is balanced in terms of 

points of view represented and the 

committee’s function. Likewise, HHS 

seeks a broad representation of 

individuals with diverse backgrounds to 

serve on HHS federal advisory 

committees. Appointment to NVAC will 

be made without discrimination based 

on age, race, ethnicity, gender, sexual 

orientation, disability, and cultural, 

religious, or socioeconomic status. 

Individuals appointed to serve as 

public members of federal advisory 

committees are classified as special 

government employees (SGEs). SGEs are 

government employees for purposes of 

the conflict-of-interest laws. Therefore, 

individuals appointed to serve as public 

members of NVAC are subject to an 

ethics review to determine whether they 

have any interests and/or activities in 

the private sector that may conflict with 

performance of their official duties as an 

NVAC member. Individuals appointed 

to serve as public members of the NVAC 

will be required to disclose information 

regarding financial holdings, 

consultancies, research grants and/or 

contracts, and the absence of an 

appearance of a loss of impartiality. 

Authority: 42 U.S.C. 300aa–5, Section 

2105 of the Public Health Service Act, 

as amended. The National Vaccine 

Advisory Committee is governed by the 

provisions of Public Law 92–463, as 

amended (5 U.S.C. Appendix 2), which 

sets forth standards for the formation 

and use of advisory committees. 

Dated: April 5, 2022. 

Ann Aikin, 

Acting Designated Federal Official, Office of 

the Assistant Secretary for Health. 

[FR Doc. 2022–09550 Filed 5–3–22; 8:45 am] 

BILLING CODE 4150–44–P 


khammond on DSKJM1Z7X2PROD with NOTICES